Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Gynecologic Oncology|September 3, 2005
Risk grouping in stage IB squamous cell cervical carcinomaGregg Van de Putte, A Kathrine Lie, Werner Vach, et al.
International Journal of Medical Sciences|June 21, 2008
Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosisRuth Holm, Gregg Van de Putte, Zhenhe Suo, et al.
Gynecologic Oncology|August 7, 2004
E-cadherin and catenins in early squamous cervical carcinomaGregg Van de Putte, Gunnar B Kristensen, Mark Baekelandt, et al.
Gynecologic Oncology|January 31, 2004
Cyclins and proliferation markers in early squamous cervical carcinomaGregg Van de Putte, Gunnar B Kristensen, A Kathrine Lie, et al.
Gynecologic Oncology|April 16, 2003
Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosisGregg van de Putte, Ruth Holm, A Kathrine Lie, et al.
Clinical & Experimental Metastasis|December 13, 2003
Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinomaVered Givant-Horwitz, Ben Davidson, Gregg van de Putte, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 28, 2015
Outcome of Epithelial Ovarian Cancer: Time for Strategy Trials to Resolve the Problem of Optimal Timing of SurgeryGregg Van de Putte, Jolien Oben, Leen Prenen, et al.
Clinical & Experimental Metastasis|April 20, 2002
Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusionsBen Davidson, Reuven Reich, Juri Kopolovic, et al.
American Journal of Clinical Pathology|February 28, 2002
Caveolin-1 expression in ovarian carcinoma is MDR1 independentBen Davidson, Iris Goldberg, Vered Givant-Horwitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2011
A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational studyBen Van Calster, Lil Valentin, Caroline Van Holsbeke, et al.
Pageof 2